Annual report pursuant to Section 13 and 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.7.0.1
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Payables and Accruals [Abstract]    
Accrued clinical operations and trials costs $ 1,647,490 $ 365,188
Accrued product development costs 713,426 152,018
Accrued compensation 778,250
Accrued other 117,289 45,073
Total $ 3,256,455 $ 562,279